360 High-Risk Vulnerability Immunization Tool V2.0 vs Resecurity Endpoint Protection Platform: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

Resecurity Endpoint Protection Platform: EPP consolidating 7 security technologies with AI-driven threat detection. built by Resecurity. Core capabilities include Pre-execution analysis and behavior analytics, Memory protection and machine learning-based detection, MITRE ATT&CK framework coverage for Windows, Linux, and Mac OS..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. Resecurity Endpoint Protection Platform differentiates with Pre-execution analysis and behavior analytics, Memory protection and machine learning-based detection, MITRE ATT&CK framework coverage for Windows, Linux, and Mac OS.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). Resecurity Endpoint Protection Platform is developed by Resecurity. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and Resecurity Endpoint Protection Platform serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Zero Day. Review the feature comparison above to determine which fits your requirements.